Gubra A/S (CPH:GUBRA)
Denmark
· Delayed Price · Currency is DKK 355.40
-19.60 (-5.23%)
At close: Mar 9, 2026
Gubra Revenue
In the year 2025, Gubra had annual revenue of 2.64B DKK with 892.25% growth. Gubra had revenue of 144.68M in the half year ending December 31, 2025, with 40.21% growth.
Revenue
2.64B
Revenue Growth
+892.25%
P/S Ratio
2.20
Revenue / Employee
9.59M
Employees
275
Market Cap
5.80B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Genmab | 23.66B |
| Coloplast | 27.89B |
| ALK-Abelló | 6.31B |
| H. Lundbeck | 24.63B |
| Ambu A/S | 6.09B |
| Zealand Pharma | 9.21B |
| Bavarian Nordic | 6.89B |